The Epidemiology of Osteoporosis in Italian Postmenopausal Women According to the National Bone Health Alliance (NBHA) Diagnostic Criteria: a Multicenter Cohort Study

Overview

Journal J Endocrinol Invest

Publisher Springer

Specialty Endocrinology

Date 2017 Sep 29

PMID 28956296

Citations 32

Authors

C Cipriani

J Pepe

F Bertoldo

G Bianchi

F P Cantatore

A Corrado

M di Stefano

B Frediani

D Gatti

A Giustina

T Porcelli

G Isaia

M Rossini

L Nieddu

S Minisola

G Girasole

M Pedrazzoni

Affiliations

Soon will be listed here.

Abstract

Purpose: The study was aimed at evaluating the prevalence of osteoporosis, defined by BMD and the National Bone Health Alliance (NBHA) criteria, and the prevalence of clinical risk factors for fractures in Italian postmenopausal women.

Methods: This is a cross-sectional, multicenter, cohort study evaluating 3247 postmenopausal women aged ≥ 50 and older in different areas of Italy in the period 2012-2014. All the participants were evaluated as far as anthropometrics; questionnaires for FRAX and DeFRA calculation were administered and bone mineral density was measured at lumbar spine, femoral neck and total hip by DXA.

Results: The prevalence of osteoporosis, as assessed by BMD and NBHA criteria was 36.6 and 57%, respectively. Mean ± SD values of FRAX and DeFRA were: 10.2 ± 7.3 and 11 ± 9.4 for major fractures, and 3.3 ± 4.9 and 3.9 ± 5.9 for hip fractures, respectively. Among clinical risk factors for fracture, the presence of previous fracture, particularly non-spine/non-hip fracture, parental history of hip fracture and current smoking were the most commonly observed.

Conclusions: Our study showed that more that the half of postmenopausal women aged 50 and older in Italy has osteoporosis on the basis of the NBHA criteria. There is a relevant high risk of femur fracture, as assessed by the FRAX and DeFRA and previous fracture, parental history of hip fracture and current smoking are the most common risk factors. The data should be considered particularly in relation to the need to increase prevention strategies on modifiable risk factors and therapeutic intervention.

Citing Articles

LPL-RH suppresses bone loss in ovariectomised rat models.

Chen W, Wang X, Wang Y, Liu D, Yue M, Wei J BMC Microbiol. 2024; 24(1):545.

PMID: 39732687 PMC: 11681754. DOI: 10.1186/s12866-024-03683-w.

Association between inflammation-related indicators and vertebral fracture in older adults in the United States: A cross-sectional study based on National Health and Nutrition Examination Survey 2013-2014.

Gou Y, Xie X, Yin H, Wu Y, Wen Y, Zhang Y Immun Inflamm Dis. 2024; 12(11):e70047.

PMID: 39508685 PMC: 11542303. DOI: 10.1002/iid3.70047.

Vitamin D and hip protectors in osteosarcopenia: a combined hip fracture preventing approach.

Giustina A, Giustina A Rev Endocr Metab Disord. 2024; 26(1):1-18.

PMID: 39352578 PMC: 11790758. DOI: 10.1007/s11154-024-09907-8.

Possible mechanisms underlying the regulation of postmenopausal osteoporosis by follicle-stimulating hormone.

Huang J, Zhang Z, He P, Zhou J Heliyon. 2024; 10(15):e35405.

PMID: 39170318 PMC: 11336567. DOI: 10.1016/j.heliyon.2024.e35405.

Olink and gut microbial metabolomics reveal new biomarkers for the prediction and diagnosis of PMOP.

Wu R, Wu J, Jin H, Ma H, Huang H, Xu W J Bone Miner Metab. 2024; 42(5):503-515.

PMID: 39153113 DOI: 10.1007/s00774-024-01545-z.

References

Wright N, Saag K, Dawson-Hughes B, Khosla S, Siris E . The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA. Osteoporos Int. 2016; 28(4):1225-1232. DOI: 10.1007/s00198-016-3865-3. View

JOHNSTON Jr C, Slemenda C, Melton 3rd L . Clinical use of bone densitometry. N Engl J Med. 1991; 324(16):1105-9. DOI: 10.1056/NEJM199104183241606. View

Yang S, Leslie W, Yan L, Walld R, Roos L, Morin S . Objectively Verified Parental Hip Fracture Is an Independent Risk Factor for Fracture: a Linkage Analysis of 478,792 Parents and 261,705 Offspring. J Bone Miner Res. 2016; 31(9):1753-9. DOI: 10.1002/jbmr.2849. View

Romagnoli E, Caravella P, Scarnecchia L, Martinez P, Minisola S . Hypovitaminosis D in an Italian population of healthy subjects and hospitalized patients. Br J Nutr. 1999; 81(2):133-7. View

Bonaccorsi G, Fila E, Cervellati C, Romani A, Giganti M, Rossini M . Assessment of Fracture Risk in A Population of Postmenopausal Italian Women: A Comparison of Two Different Tools. Calcif Tissue Int. 2015; 97(1):50-7. DOI: 10.1007/s00223-015-0009-2. View

Wright N, Saag K, Curtis J, Smith W, Kilgore M, Morrisey M . Recent trends in hip fracture rates by race/ethnicity among older US adults. J Bone Miner Res. 2012; 27(11):2325-32. DOI: 10.1002/jbmr.1684. View

Pedrazzoni M, Girasole G, Bertoldo F, Bianchi G, Cepollaro C, del Puente A . Definition of a population-specific DXA reference standard in Italian women: the Densitometric Italian Normative Study (DINS). Osteoporos Int. 2003; 14(12):978-82. DOI: 10.1007/s00198-003-1521-1. View

Pepe J, Cipriani C, Cantatore F, Fabbri A, Pola E, Vinicola V . The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis. J Endocrinol Invest. 2017; 40(6):663-667. DOI: 10.1007/s40618-017-0636-8. View

Kanis J, Oden A, McCloskey E, Johansson H, Wahl D, Cooper C . A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012; 23(9):2239-56. PMC: 3421108. DOI: 10.1007/s00198-012-1964-3. View

10.

Vestergaard P, Mosekilde L . Fracture risk associated with smoking: a meta-analysis. J Intern Med. 2003; 254(6):572-83. DOI: 10.1111/j.1365-2796.2003.01232.x. View

11.

Kanis J, Johansson H, Johnell O, Oden A, De Laet C, Eisman J . Alcohol intake as a risk factor for fracture. Osteoporos Int. 2004; 16(7):737-42. DOI: 10.1007/s00198-004-1734-y. View

12.

Alonso N, Ralston S . Unveiling the mysteries of the genetics of osteoporosis. J Endocrinol Invest. 2014; 37(10):925-34. DOI: 10.1007/s40618-014-0149-7. View

13.

Curtis E, van der Velde R, Moon R, van den Bergh J, Geusens P, de Vries F . Epidemiology of fractures in the United Kingdom 1988-2012: Variation with age, sex, geography, ethnicity and socioeconomic status. Bone. 2016; 87:19-26. PMC: 4890652. DOI: 10.1016/j.bone.2016.03.006. View

14.

Curtis E, Moon R, Harvey N, Cooper C . The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide. Bone. 2017; 104:29-38. PMC: 5420448. DOI: 10.1016/j.bone.2017.01.024. View

15.

DAmelio P, Spertino E, Martino F, Isaia G . Prevalence of postmenopausal osteoporosis in Italy and validation of decision rules for referring women for bone densitometry. Calcif Tissue Int. 2013; 92(5):437-43. DOI: 10.1007/s00223-013-9699-5. View

16.

Wright N, Looker A, Saag K, Curtis J, Delzell E, Randall S . The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res. 2014; 29(11):2520-6. PMC: 4757905. DOI: 10.1002/jbmr.2269. View

17.

Cavalli L, Guazzini A, Cianferotti L, Parri S, Cavalli T, Metozzi A . Prevalence of osteoporosis in the Italian population and main risk factors: results of BoneTour Campaign. BMC Musculoskelet Disord. 2016; 17(1):396. PMC: 5027125. DOI: 10.1186/s12891-016-1248-8. View

18.

Lewiecki E, Binkley N . What we don't know about osteoporosis. J Endocrinol Invest. 2016; 39(5):491-3. DOI: 10.1007/s40618-016-0442-8. View

19.

Ballane G, Cauley J, Luckey M, Fuleihan G . Secular trends in hip fractures worldwide: opposing trends East versus West. J Bone Miner Res. 2014; 29(8):1745-55. DOI: 10.1002/jbmr.2218. View

20.

Siris E, Boonen S, Mitchell P, Bilezikian J, Silverman S . What's in a name? What constitutes the clinical diagnosis of osteoporosis?. Osteoporos Int. 2012; 23(8):2093-7. DOI: 10.1007/s00198-012-1991-0. View